Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection

J Virol. 2001 Apr;75(8):3537-46. doi: 10.1128/JVI.75.8.3537-3546.2001.

Abstract

We have studied the pathways of regulation of cytokine and cell cycle control proteins during infection of human B lymphocytes by Epstein-Barr virus (EBV). Among 30 cytokine RNAs analyzed by the RNase protection assay, tumor necrosis factor alpha (TNF-alpha), granulocyte colony-stimulating factor, lymphotoxin (LT), and LTbeta were found to be regulated within 20 h of EBV infection of primary B cells. Similar results were obtained using the estrogen-regulated EBNA-2 cell line EREB2.5, in which RNAs for LT and TNF-alpha were induced within 6 h of activation of EBNA-2. Expression of Notch also caused an induction of TNF-alpha RNA. The induction of TNF-alpha RNA by EBNA-2 was indirect, and constitutive expression of either LMP-1 or c-myc proteins did not substitute for EBNA-2 in induction of TNF-alpha RNA. Cyclin D2 is also an indirect target of EBNA-2-mediated transactivation. EBNA-2 was found to activate the cyclin D2 promoter in a transient-transfection assay. A mutant of EBNA-2 that does not bind RBP-Jkappa retained some activity in this assay, and activation did not depend on the presence of B-cell-specific factors. Deletion analysis of the cyclin D2 promoter revealed that removal of sequences containing E-box c-myc consensus DNA binding sequences did not reduce EBNA-2-mediated activation of the cyclin D2 promoter in the transient-transfection assay. The results indicate that cytokines are an early target of EBNA-2 and that EBNA-2 can regulate cyclin D2 transcription in EBV-infected cells by mechanisms additional to the c-myc pathway.

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Anisomycin / pharmacology
  • B-Lymphocytes / metabolism*
  • B-Lymphocytes / virology*
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cell Cycle Proteins / genetics*
  • Cells, Cultured
  • Cyclin D2
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclins / genetics
  • Cyclins / metabolism
  • Cycloheximide / pharmacology
  • Cytokines / genetics*
  • Cytoskeletal Proteins
  • Epstein-Barr Virus Nuclear Antigens / genetics
  • Epstein-Barr Virus Nuclear Antigens / metabolism*
  • Estrogens / pharmacology
  • Fluorescent Antibody Technique
  • Gene Expression Regulation* / drug effects
  • Granulocyte Colony-Stimulating Factor / genetics
  • Herpesvirus 4, Human / physiology*
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • LIM Domain Proteins
  • Lymphotoxin-alpha / genetics
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Microtubule-Associated Proteins / metabolism
  • Mutation / genetics
  • Nuclease Protection Assays
  • Promoter Regions, Genetic / genetics
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, Notch
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / genetics
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Suppressor Proteins*
  • Viral Proteins

Substances

  • Adaptor Proteins, Signal Transducing
  • CCND2 protein, human
  • Carrier Proteins
  • Cell Cycle Proteins
  • Cyclin D2
  • Cyclins
  • Cytokines
  • Cytoskeletal Proteins
  • EBNA-2 protein, Human herpesvirus 4
  • Epstein-Barr Virus Nuclear Antigens
  • Estrogens
  • Intracellular Signaling Peptides and Proteins
  • LIM Domain Proteins
  • Lymphotoxin-alpha
  • Membrane Proteins
  • Microtubule-Associated Proteins
  • PDLIM7 protein, human
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • Receptors, Notch
  • Tumor Necrosis Factor-alpha
  • Tumor Suppressor Proteins
  • Viral Proteins
  • Granulocyte Colony-Stimulating Factor
  • Cyclin-Dependent Kinase Inhibitor p27
  • Anisomycin
  • Cycloheximide